Table 2: Pre-operative drug therapy.
|
|
Group A (n = 58) |
Group B (n = 18) |
|
Phenoxybenzamine |
42 (72.4 %) |
|
|
Phenoxybenzamine + Beta-blocker |
13 (22.4 %) |
|
|
Phenoxybenzamine + Alpha-blocker |
1 (1.7 %) |
|
|
Phenoxybenzamine + Calcium channel blocker |
2 (3.4 %) |
|
|
Doxazosin |
2 (11.1 %) |
|
|
Doxazosin + Beta-blocker |
|
5 (27.8%) |
|
Labetalol |
|
9 (50%) 9 |
|
Calcium channel blocker + Beta-blocker |
2 (11.1%) |